Home Search
cancer - search results
If you're not happy with the results, please do another search
Bringing together biomedical researchers and computer scientists to create personalized medicine
Artificial Intelligence holds the potential to significantly contribute to the shift towards a more personalized approach. Having multidisciplinary skills and establishing working groups that bring together biomedical researchers and computer scientists is necessary to attain this ambitious goal.
WHO outline’s responsible regulations needed for Artificial Intelligence in healthcare
The World Health Organization (WHO) recently published a new document outlining essential regulatory considerations for applying artificial intelligence (AI) in healthcare.
Prof Mark Lawler – Queen’s University Belfast, UK
Professor Mark Lawler is Professor of Digital Health and Chair in Translational Cancer Genomics at Queen’s University Belfast
He is Co-lead of the All Island Cancer Research Institute (AICRI), Scientific Director of DATA-CAN, the UK’s Health Data Research Hub for Cancer and Chair of the International Cancer Benchmarking Partnership, which...
Current and future therapy for BRAF-mutant pediatric glioma
Professor Peter J. Houghton from the Greehey Children’s Cancer Research Institute discusses new approaches to pediatric cancer treatment specifically for BRAF-mutant pediatric glioma.
Personalized medicine: “Tyranny of the gene”
Dr Priya Hays, Ph.D., CEO/Science Writer at Hays Documentation Specialists, LLC, responds to “Tyranny of the Gene.” Is personalized medicine a threat to public health? Not really, but yes, it’s an argument for price controls and perhaps more regulations; we hear.
Understanding T lymphocytes inner workings to harness therapeutic potential
Leslie J. Berg, PhD from the University of Colorado, Anschutz School of Medicine, sheds light on understanding the inner workings of T lymphocytes to harness their therapeutic potential.
Leslie J. Berg, PhD – University of Colorado, Anschutz School of Medicine
Dr. Berg is currently Professor and Chair of the Department of Immunology & Microbiology and Director of the Human Immunology and Immunotherapy Initiative at the University of Colorado-Anschutz School of Medicine
She received her B.A. degree in Biology from Harvard University and her Ph.D. degree in Molecular Biology from the...
Changes in public health: Highlighting the positive aspects of the COVID-19 pandemic
Zisis Kozlakidis and Caboux Elodie from the International Agency for Research on Cancer discuss how the COVID-19 pandemic accelerated the adoption of changes in public health interventions and patient care.
How AI can become the NHS’s lifeline: Protecting healthcare staff with technology
Adrian Sutherland, Strategy Director (Global Healthcare) at Endava, outlines how artificial intelligence technologies can be a valuable tool in supporting healthcare staff and improving patient outcomes.
Functional Immune Repertoire Analysis
Functional Immune Repertoire Analysis: Finding novel ways to measure, understand and advance vaccine-mediated protection towards personalized vaccination strategies.
EPA shines a spotlight on green chemistry innovations
Jennie Romer, Deputy Assistant Administrator for Pollution Prevention at EPA’s Office of Chemical Safety and Pollution Prevention (OCSPP) in the U.S., shines the spotlight on green chemistry innovations.
AI’s potential to predict and prevent sudden cardiac death
Research conducted in France suggests that using Artificial Intelligence to analyse medical data in electronic health records may hold promise in predicting sudden cardiac death
In their study, the researchers examined the electronic health records of 25,000 individuals who had experienced sudden cardiac death and 70,000 individuals who had been...
Mesothelioma: The unravelling of a perplexing puzzle
Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, explores the key challenges in mesothelioma prevention, diagnosis and treatment.
NHS waiting lists could reach 8 million by summer 2024
According to modelling work from the Health Foundation charity, the NHS waiting lists may exceed eight million by next summer, even if doctor strikes stop.
Understanding glioma-related epilepsy: Ongoing research and treatments
UK-based charity, Epilepsy Action, outlines how glioma-related epilepsy can heavily impact a person’s quality of life, drawing on the need for further research and treatment options.
The cellular mechanisms of kidney fibrosis: A hitherto understudies aspect of polycystic kidney disease
In this exclusive Q&A session with Dr. Andras Kapus, we unravel the complexities of chronic kidney disease in general and Polycystic Kidney Disease (PKD) in particular, and delve into the ongoing research efforts aimed at combatting kidney fibrosis.
The role of prescribing practices in managing chronic pain with opioids
Norm Buckley and Jason Busse from the Michael G. DeGroote Institute for Pain Research and Care discuss prescribing practices, managing chronic pain with opioids, and the contribution of licit and illicit opioids towards the Canadian opioid crisis.
The Mediterranean Diet (MedDiet): There’s more to it than olives and grape leaves
Centered around the consumption of whole and unprocessed foods, we hear how following a Mediterranean diet can bring long-term health benefits, including mitigating the risk of common diseases.
Ensuring adequate dementia care: The beginning of the end of Alzheimer’s?
Colin Capper, Associate Director of Evidence and Involvement at Alzheimer’s Society, argues that we need improved dementia care and further innovations for people living with dementia today while we wait for the breakthroughs of tomorrow
The crucial role of scavengers in ecosystem health
Animal scavengers’ role in maintaining ecosystem balance is often overlooked. Dr Laurel Lynch from the University of Idaho tells us about her important research on how scavenging by Tasmanian devils influences ecosystem processes.